AcrB Trimer Stability and Efflux Activity, Insight from Mutagenesis Studies by Yu, Linliang et al.
AcrB Trimer Stability and Efflux Activity, Insight from
Mutagenesis Studies
Linliang Yu, Wei Lu, Yinan Wei*
Department of Chemistry, University of Kentucky, Lexington, Kentucky, United States of America
Abstract
The multidrug transporter AcrB in Escherichia coli exists and functions as a homo-trimer. The assembly process of obligate
membrane protein oligomers, including AcrB, remains poorly understood. In a previous study, we have shown that
individual AcrB subunit is capable of folding independently, suggesting that trimerization of AcrB follows a three-stage
pathway in which monomers first fold, and then assemble. Here we destabilized the AcrB trimer through mutating a single
Pro (P223) in the protruding loop of AcrB, which drastically reduced the protein activity. We replaced P223 separately with
five residues, including Ala, Val, Tyr, Asn, and Gly, and found that AcrBP223G was the least active. Detailed characterization of
AcrBP223G revealed that the protein existed as a well-folded monomer after purification, but formed a trimer in vivo. The
function of the mutant could be partly restored through strengthening the stability of the trimer using an inter-subunit
disulfide bond. Our results also suggested that the protruding loop is well structured during AcrB assembly with P223
served as a ‘‘wedge’’ close to the tip to stabilize the AcrB trimer structure. When this wedge is disrupted, the stability of the
trimer is reduced, accompanied by a decrease of drug efflux activity.
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Introduction
The inherit difficulty of expression and purification of membrane
proteins has drastically hindered studies of these important players
of cellular functions. In the past decade, there has been a leap in the
effort of solving crystal structures of membrane proteins. As of Jun.
2011, there are almost 300 unique structures of membrane proteins
intheprotein databank.Theavailabilityofanincreasingnumberof
protein structures has set the stage for studies of the dynamic life
cycles of membrane proteins, starting from the foldingand assembly
of nascent polypeptide chains in the membrane that leads to
functional proteins. Specifically, the assembly process of obligate
homo-oligomeric membrane proteins remains elusive [1–3].
Obligate oligomers exist and function exclusively in their oligomeric
form. However, it was not clear how multiple subunits, after their
co-translational membrane insertion, assemble into the final
functional state. Toward answering these questions, we chose an
Escherichia coli inner membrane protein AcrB as a model system to
study its oligomerization.
AcrB is an obligate homo-trimer. It associates with the peripheral
protein AcrA and outer membrane protein TolC to form a complex
that spans from the cytoplasm all the way to the exterior of the cell
[4–7]. AcrAB-TolC and its homologues, members of the resistance-
nodulation-cell division (RND) transporter family, are major efflux
systems that make Gram-negative bacteria resistant against a wide
range ofcytotoxiccompounds[8,9].The structure ofAcrB has been
solved byx-ray crystallographyin both the apoand substrate-bound
conformations [10–15]. Based on the crystal structure of AcrB, a
conformational cycling model for drug transport has been proposed
[16–19].However,crystalstructurescannot provideinsightintothe
biogenesis process of an AcrB trimer. Recently, we have created a
monomeric AcrB mutant, AcrBDloop, in which we deleted 17
residues from a protruding loop [20] (Figure 1). The loop is
obviously important for inter-subunit interactions, as it penetrates
deep into a tunnel in the neighboring subunit. While at the same
time, it stretches away from the rest of the polypeptide chain, not
making tertiary contact with any residues from the same subunit.
We found that AcrBDloop completely lost its transport activity and
failedto assemblyintoa trimer, whilehada similar tertiarystructure
as subunits in the AcrB trimer. These results indicated that
monomeric AcrB was capable of folding independently, suggesting
that oligomerization of AcrB occurred through a three-stage
pathway, in which nascent polypeptide chains first folded
independently into monomers, which then assembled into func-
tional trimers.
To further probe the role and structural flexibility of the
protruding loop during AcrB trimerization, we mutated a
conserved Pro (P223) and characterized the structure and function
of the resultant mutants. We found that replacing P223 with other
residues drastically decreased the stability of the AcrB trimer and
caused a loss of function, which could be regained partially
through connecting subunits in a trimer covalently using a
disulfide bond.
Results
Effect of P223 mutation on AcrB drug efflux activity
The protruding loop of AcrB is composed of 30 residues, which
form two short anti-parallel b-strands in the middle (Figure 1).
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28390There are two consecutive Pro in the loop, P223 and P224.
Sequence alignment with other AcrB homologues revealed that
while P223 was conserved in all sequences, P224 was not (Figure 2).
Based on the crystal structure, P223 locates close to the tip of the
loop, where it induces the loop to form a kink (Figure 1C and 1D).
Pro is unique among twenty common amino acids in that its
backbone conformation is much more rigid and can only assume a
very limited set of Q and y angles. The rigidity of Pro has been
exploited by many proteins to serve specific structural and
functional roles [21–24]. P223 seemed to be playing an important
role in maintaining the specific structure of the loop and making
inter-subunit interaction in AcrB. To examine if this is the case, we
created several single mutations, in which P223 was replaced with
residues of various size, shape, and polarity, including Gly
(AcrBP223G), Ala (AcrBP223A), Val (AcrBP223V), Tyr (AcrBP223Y),
and Asn (AcrBP223N).
To examine the effect of these mutations on the function of
AcrB, we tested the minimum inhibitory concentration (MIC) of
the mutants to five established AcrB substrates [25] (Table 1). As
described in the materials and methods session, plasmids encoding
different AcrB mutants were transformed into an acrB gene
knockout E. coli strain, BW25113DacrB, for activity assay. The
same strain transformed with a plasmid encoding wild type (WT)
AcrB or an empty vector without the acrB gene (pQE70) were used
as positive and negative controls, respectively. As shown in Table 1,
when replaced with different residues, all P223 mutations
drastically decreased the activity of the efflux pump. Among these
mutations, P223G had the most drastic detrimental effect on
protein activity. The effects of P223V and P223Y were
comparable, which were greater than the effects of P223A and
P223N. A comparison of the effects of different mutations revealed
that the extent of disruption of AcrB function did not correlate
with the size of the side chains. P223 locates close to the tip of the
long loop (Figure 1B). The binding pocket of P223 is semi-open,
formed by residues W187, Y275, Q584, A777, and R780 from the
neighboring subunit. We created structure models of AcrBP223Y
and AcrBP223N using the online server of SWISS-MODEL
(Figure 1C) [26]. As shown in Figure 1C, the bulky side chain of
Tyr and Asn rotated out of the binding pocket and was partially
exposed. Therefore, little structural rearrangement would be
necessary to accommodate mutations of P223. The energetic
penalty associated with exposing a hydrophobic side chain could
be the reason why P223Y and P223V were the least active mutants
among all five. Backbone flexibility seemed to play a very
important role, since P223G, which introduced the largest
increment of backbone flexibility, was the least active. In terms
of the neighboring and non-conserved residue P224, the
replacement with Gly had no observable effect on protein function
(Table 1).
Structural Characterization of AcrBP223G
We chose AcrBP223G for further characterization, since it had
the most dramatic effect on the function of AcrB. To determine
the effect of P223 mutation on the protein expression level, we
Figure 1. Crystal structure of AcrB. A. AcrB trimer with each subunit color coded (created from 2HRT.pdb). B. Zoom in view of the loop region
(grey box in A). Residues P223 and V225 from the red subunit, and A777 from the blue subunit are highlighted using ball-and-stick models. C.
Binding pocket of P223 (red). Residues that form the binding pocket of P223 were shown (orange). The conformations of Y223 (blue) and N223
(green) were also shown superimposed on top of P223. D. Ribbon diagram of the protruding loop at a different angle. Residues P223 and V225 are
highlighted using ball-and-stick models. Position of G220 is highlighted in green.
doi:10.1371/journal.pone.0028390.g001
Figure 2. Sequence alignment of the loop. The numbers indicate
positions of the starting and ending residues in the sequence of E. coli
AcrB. Asterisks, colons and periods indicate identical, conserved and
semi-conserved residues, respectively. The sequences are: EC, AcrB from
E. coli; PA, MexB from Pseudomonas aeruginosa PAO1; NM, MtrD from
Neisseria meningitidis 8013; HC, hypothetical protein HcanM9_00968
from Helicobacter canadensis MIT 98-5491; SE, acridine efflux pump from
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2; LL,
acriflavine resistance protein B from Legionella longbeachae D-4968; SM,
hydrophobe/amphiphile efflux-1 (HAE1) from Tenotrophomonas mal-
tophilia R551-3; MC, RND system efflux pump AcrB from Moraxella
catarrhalis RH4.
doi:10.1371/journal.pone.0028390.g002
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AcrB or AcrBP223G and conducted quantitative Western blot
analysis using an anti-AcrB antibody (Figure 3A). There was no
significant difference between the expression levels of WT AcrB
and AcrBP223G, indicating that the increase of drug susceptibility
was not due to a decrease of protein expression level.
AcrBP223G could be purified with similar yield and purity as WT
AcrB, as shown in Figure 3B. We collected far UV circular
dichroism (CD) spectra of both proteins to compare their
secondary structure compositions (Figure 4A). Both proteins had
high a-helical contents, consistent with the crystal structure of
AcrB. The two spectra overlapped reasonably well, indicating that
the secondary structure of the mutant was similar to that of the
WT protein.
Thermal denaturation is a useful experiment in determining the
stability of membrane proteins in vitro [27,28]. With the slow
increase of temperature, the purified proteins gradually lost their
helical secondary structures as monitored via the change of
ellipticity at 222 nm (Figure 4B). Approximately 40% of helical
content in the protein was lost when the temperature increased
from 4 to 98uC for both WT AcrB and AcrBP223G, which was
consistent with earlier observations [20]. The melting curves of the
two proteins were close to each other, with the ellipticity for WT
AcrB slightly lower at 98uC.
Limited proteolysis has been used widely to reveal the presence
of compact domains, assess the structural flexibility, and examine
the topology of proteins [29–31]. In this study, we digested WT
AcrB and AcrBP223G using trypsin under mild conditions to
compare their structural differences. WT AcrB was more resistant
to trypsin digestion than AcrBP223G (Figure 5). Under our
experimental condition, AcrBP223G was completely digested to
small fragments in 40 minutes, while WT AcrB retained a decent
amount of full length protein during the same digestion period. As
a negative control, we have also digested a fully unfolded AcrB as
previously described [20]. Unfolded AcrB was completely digested
under the experimental condition within 5 min (data not shown).
The proteolysis results indicated that in AcrBP223G, trypsin
recognition sites (Arg and Lys) were more exposed compared to
the same residues in WT AcrB. However, they were much more
protected than digestion sites in fully unfolded AcrB. Two
structural changes could have caused this effect. First, P223 to
Table 1. MIC (mg/ml) of BW25113DacrB containing plasmid
encoded AcrB.
Plasmids Ery* Nov R6G TPP Tet
pQE70-AcrB 80 160–320 320–640 640 1.28
pQE70 2.5 5 5 5 0.32
pQE70-AcrBP224G 80 160 320 320 1.28
pQE70-AcrBP223G 5 1 02 02 0 0 . 3 2
pQE70-AcrBP223A 10 40 80 40 0.64
pQE70-AcrBP223V 5 20 40–80 40 0.64
pQE70-AcrBP223Y 5 20 40–80 20 0.64
pQE70-AcrBP223N 5 4 08 04 0 0 . 6 4
pQE70-AcrBV225C 80 160 320 640 1.28
pQE70-CLAcrBA216C/I234C 80 160 640 320 1.28
pQE70-CL
AcrBP223G/A216C/I234C
5 1 02 01 0 0 . 3 2
pQE70-CLAcrBP223G/V225C 2 . 5 555 0 . 3 2
pQE70-CL
AcrBP223G/V225C/A777C
40 40 160 80 0.64
pQE70-CLAcrBV225C/A777C 80 160 320 640 1.28
*Drugs tested were Erythromycin (Ery), Novobiocin (Nov), Rhodamine 6G (R6G),
Tetraphenylphosphonium (TPP), and Tetracycline (Tet).
doi:10.1371/journal.pone.0028390.t001
Figure 3. Comparison of the expression levels of WT AcrB and
AcrBP223G.A .Western blot analysis of membrane vesicles extracted
from BW25113DacrB expressing WT AcrB (WT) or AcrBP223G (P223G).
Each sample was diluted 1, 5, and 25 folds. B. SDS-PAGE analysis of
purified WT AcrB and AcrBP223G. The expression levels of the WT and
AcrBP223G are similar.
doi:10.1371/journal.pone.0028390.g003
Figure 4. CD spectra of purified WT AcrB and AcrBP223G.A .
Wavelength scans at the far UV region of WT AcrB (black) and AcrBP223G
(grey) superimposed well onto each other, indicating that the two
proteins had similar secondary structure contents. B. Temperature
denaturation curves of WT AcrB (black) and AcrBP223G (grey). The
ellipticity values monitored at 222 nm were normalized to the reading
at 4uC. The thermal stabilities of the two proteins were similar.
doi:10.1371/journal.pone.0028390.g004
Figure 5. Limited trypsin digestion of purified WT AcrB (left)
and AcrBP223G (right). Lanes 2 to 5 were samples taken at 10, 20, 40,
and 60 min into the digestion, respectively. Lane 1 was a control
sample in which no trypsin was added. WT AcrB was digested slower
than AcrBP223G.
doi:10.1371/journal.pone.0028390.g005
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protein to make it less compactly folded. Under this condition,
potential trypsin digestion sites will be less protected than similar
sites in a more compactly folded structure. Second, the mutation
could have caused AcrB trimer to dissociate, under which
condition the inter-subunit interface, which was protected in an
AcrB trimer, would be exposed upon trimer dissociation [20].
To characterize the tertiary structure of AcrBP223G, we used a
disulfide-trapping method developed earlier in our laboratory
[32]. We have previously identified seven pairs of residues in the
periplasmic domain of AcrB that are within the disulfide bond
distance. Mutations of these residues to Cys and formation of
disulfide bonds at these positions have little effect on the function
of AcrB. We have used these Cys-pair mutants as reporters to
investigate the tertiary structure of AcrB, in which the formation of
disulfide bond could be detected through labeling with a
fluorescent probe. If the structure of a mutant is similar to that
of WT AcrB, we expect to see a similar fluorescent labeling profile
for the Cys pair reporters in both proteins. Figure 6A showed the
concept of detecting disulfide bond using fluorescent labeling.
Briefly, protein was purified in the presence of iodoacetamide
(IAM), which blocked free thiols but did not affect disulfide bond.
After purification, protein samples were reduced using dithiothre-
itol (DTT), and then labeled using a thiol-specific fluorescent
probe, fluorescein-5-maleimide (Flu-MAL). Under this experi-
mental condition, only proteins that contain disulfide bond in their
native structure would be labeled and fluoresce (third lane in each
gel picture in Figure 6C). In each experiment, we have also
included internal positive and negative controls (first and second
lanes in each gel picture in Figure 6C, respectively). In the positive
control, proteins were purified in the absence of IAM and then
reduced with DTT before labeling. Therefore, all proteins that
contained Cys, either in the free thiol or disulfide bond form,
would be labeled. In the negative control, IAM was present during
protein purification, but the purified samples were not reduced
before labeling. Therefore, no protein should be labeled.
We used 4 Cys-pair reporters established previously to evaluate
the tertiary structure of AcrBP223G (Figure 6B). In addition, we
have created a new reporter Cys pair in this study, A216C–I234C.
This pair exists in the loop. We used it to detect potential
conformational changes in the loop. We have confirmed that
disulfide bond formed between C216 and C234 when they were
introduced into a Cys-less AcrB (CLAcrB) construct, in which the
two intrinsic Cys in the sequence of AcrB were replaced with Ala.
In addition, the mutations and formation of disulfide bond had no
effect on the drug efflux activity of AcrB (Table 1). Two pictures of
SDS-PAGE gels were shown for each protein, one visualized
under fluorescence light without staining and the other stained
with coomassie blue dye. Coomassie blue stain revealed the
loading amount in each lane, while the fluorescence image
reflected the formation of disulfide bond. As discussed above, the
first two lanes were positive and negative controls, respectively.
The third lane revealed the presence of disulfide bond. For each
reporter Cys pair tested in the presence of P223G mutation, the
fluorescence in the third lane was comparable to that of the WT
AcrB, indicating that the disulfide formed similarly as in the WT
protein. Furthermore, the new reporter Cys pair, 216–234,
showed that the structure of the loop did not change significantly
compared to that of the WT protein. These results suggested that
the P223G mutation did not change the tertiary structure of the
protein.
AcrBP223G Exists as Monomer in vitro and Forms Trimer in
vivo
To evaluate the quaternary structure of AcrBP223G, we analyzed
purified AcrBP223G using blue native (BN)-PAGE. BN-PAGE is a
powerful, convenient and inexpensive technique to determine the
oligomeric state of membrane proteins and identify physiological
protein-protein interactions [33,34]. It has been used to confirm
that the oligomer state of wild-type AcrB as a trimer [18]. As
shown in Figure 7A, WT AcrB migrated as a trimer as expected,
while AcrBP223G migrated as a monomer. The BN-PAGE result
indicated that purified AcrBP223G existed as monomer, which
explained its decreased tolerance to trypsin digestion.
Since AcrBP223G had a low level of residual activity, we
speculated at least a small portion of the protein should exist as
trimer in vivo, since AcrB function exclusively as trimers (Table 1).
Figure 6. Disulfide trapping analysis of AcrB tertiary structure. A. Schematic illustration of the blocking-reducing-labeling procedure. B. The
locations of reporter Cys pairs in the structure of AcrB were highlighted using black circles and blue ball-and-stick models. Residue numbers of the
Cys mutations were marked. C. AcrB tertiary structure as revealed by the disulfide trapping method. The extents of disulfide bond formation for each
reporter Cys pair were very similar in AcrBP223G as compared to WT AcrB. Therefore, the overall conformation, or tertiary structure, of AcrBP223G was
very similar to that of WT AcrB.
doi:10.1371/journal.pone.0028390.g006
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mutations in AcrBP223G, V225C and A777C (Figure 1B). The
intrinsic Cys in AcrB was removed to avoid interference. Seeger et
al. have shown that C225 and C777 formed inter-subunit disulfide
bond when introduced into the sequence of AcrB, which
covalently connected subunits in an AcrB trimer without affecting
protein function [35]. We extracted membrane vesicles from
BW25113DacrB expressing CLAcrBP223G/V225C/A777C in the pres-
ence of IAM and subjected the sample to SDS-PAGE and Western
blot analysis with or without the addition of DTT (Figure 7B). In
the absence of DTT, a clear band is visible at the high molecular
weight range, indicating the protein formed trimers in vivo. In the
presence of DTT, the high molecular weight species dissociated to
form monomers. BW25113DacrB expressing WT AcrB was used as
a control. Only monomer band was visible both in the presence
and absence of DTT. Next, we also analyzed purified
CLAcrBP223G/V225C/A777C using BN-PAGE (Figure 7A). The
protein migrated as trimers in the absence of DTT, which could
be reduced into monomers in the presence of DTT. These results
suggested that the C225–C777 disulfide bond effectively trapped
CLAcrBP223G/V225C/A777C trimers. Since AcrB trimer makes direct
contact with AcrA, we further examined if the absence of AcrA
would affect the efficiency of disulfide bond formation between
C225–C777. We expressed both CLAcrBV225C/A777C and
CLAcrBP223G/V225C/A777C in E. coli strain AG100A, which is
deficient in both acrA and acrB genes. We found that the efficiency
of disulfide bond formation in both proteins were not affected,
indicating that the presence of AcrA was not necessary to trap the
AcrB trimer (data not shown). The capability of the protein to
form trimer in the cell membrane further confirmed the structural
characterization results discussed above, in which we found that
purified AcrBP223G had similar secondary and tertiary structures to
WT AcrB.
Since AcrB functions in the trimeric form, we examined if the
introduction of V225C and A777C mutation enhanced the
function of AcrBP223G (Table 1). We first introduced the V225C
mutation into AcrBP223G to create AcrBP223G/V225C.V 2 2 5i si n
the loop, close to P223. We found that this mutation had a
slightly detrimental effect on the activity of the mutant and
further decreased the MIC for some substrates. To further
examine the effect of V225C mutation on the activity of AcrB, we
introduce the mutation into a wild type AcrB background. We
found that the V225C mutation had little effect on AcrB activity
(Table 1). We speculate that V225C mutation may have a small
destabilizing effect on AcrB trimer. However, the effect alone was
too small to cause an observable change of activity. When
introduced into a P223G mutant, the combined effect was larger
than the impact of P223G alone and thus caused a bigger drop of
activity. Next, we introduced A777C mutation. The V225C/
A777C double mutation partially restored the function loss
caused by P223G mutation and increased the MICs for several
substrates to levels close to that of the wild type protein,
suggesting that the formation of disulfide bond between C225
and C777 of neighboring subunits might have stabilized the AcrB
trimer and largely restored its activity.
To further confirm that it was the formation of disulfide bond
between C225 and C777 that stabilized the AcrB trimer and
reduced the function loss caused by P223G mutation, we
conducted the drug susceptibility assay in the presence of
4 mM DTT (Table 2). Our data showed that the addition of
4 mM DTT had no effect on the drug susceptibility of
BW25113DacrB containing WT AcrB, AcrBP223G, or the empty
plasmid pQE70, but specifically reduced the MIC of
BW25113DacrB containing CLAcrBP223G/V225C/A777C. Mem-
brane vesicles from the corresponding strain were extracted and
analyzed using Western blot analysis without further addition of
DTT. A significant portion of CLAcrBP223G/V225C/A777C trimer
was reduced to monomers, consistent with the observed decrease
of activity (data not shown).
Discussion
In an effort to understand the AcrB trimerization process and
the inter-subunit interactions that lead to trimerization, we have
previously developed a disulfide trapping method to characterize
AcrB tertiary structure in membrane and created a well folded
monomeric AcrB mutant. In this study, we investigated the role
of a protruding loop during AcrB trimerization by studying the
effect of mutating a conserved residue, P223. Based on the crystal
structure of AcrB, each subunit contains a protruding loop, which
extends deep into a tunnel in the neighboring subunit. The loop-
to-tunnel interaction is apparently very important to the
formation and stability of AcrB trimer. The unique backbone
structure of P223 induces the loop to form a kink close to the tip
(Figure 1), which suggests that it may function as a wedge to lock
the loop in place and stabilize the trimer structure. As expected,
the mutation of P223 into other amino acids, especially Gly,
drastically reduced the activity of AcrB. However, AcrBP223G was
different from a monomeric AcrB mutant, AcrBDloop,w h i c hw e
created previously. AcrBDloop was completely functionless while
AcrBP223G still had a very low level of activity, which implied that
at least a small portion of the protein should still exist as trimers in
vivo. Subsequently, we successfully trapped trimers formed by
mutant containing P223G mutation using an inter-subunit
disulfide bond, C225–C777. The stability of AcrBP223G trimer
Figure 7. Quaternary structure analyses. A. BN-PAGE analyses of
freshly purified WT AcrB (lane 1), AcrBP223G (lane 2), CLAcrBP223G/A225C/V777C
in the absence of DTT (lane 3), and CLAcrBP223G/A225C/V777C in the
presence of 4 mM DTT (lane 4). Positions of molecular markers were
marked on the left of the gel (in kD). A 4–20% gradient gel was used in
this experiment. B. Western blot analysis of membrane vesicles
extracted from BW25113DacrB expressing WT AcrB (lanes 1 and 3) or
CLAcrBP223G/A225C/V777C (lanes 2 and 4) in the absence (lanes 1 and 2) or
presence (lanes 3 and 4) of 4 mM DTT.
doi:10.1371/journal.pone.0028390.g007
Table 2. MIC (mg/ml) of BW25113DacrB containing plasmid
encoded AcrB measured in the presence (no bold) or absence
(bold) of 4 mM DTT.
Plasmids Ery Ery TPP TPP
pQE70-AcrB 80 80 640 640
pQE70 2.5 2.5 5 5
pQE70-AcrBP223G 5 5 20 20
pQE70-CLAcrBP223G/V225C/A777C 40 20 80 20–40
doi:10.1371/journal.pone.0028390.t002
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dissociated upon detergent extraction and purification.
It is intriguing to speculate how the interaction between the
protruding loop and the corresponding tunnel in the neighboring
subunit is established. We probed the inter-subunit interface
between neighboring subunits in AcrB using the online server of
ProtorP [36]. When AcrB trimerizes, the loop-and-tunnel
interaction between neighboring subunits contributes approxi-
mately 1,600 A ˚ 2 of decreased accessible surface area (ASA),
which is 46.9% of the overall inter-subunit interface. Studies have
shown that protein-protein interactions with interfaces larger
than ,1000 A ˚ 2 are likely to undergo conformational changes
upon binding [37,38]. There are three possible scenarios: the
loop adopts its final structure first while the tunnel retains a
certain degree of flexibility and folds around the loop (loop first);
the tunnel adopts its final structure first while the loop retains a
certain degree of flexibility and folds once it settles inside the
tunnel (tunnel first); or both loop and tunnel are flexible and
induce each other to fold into the final conformation. To
investigate the flexibility of the loop during trimerization, we
created a reporter Cys-pair in the loop, C216–C234. We found
that this pair of Cys formed disulfide bond in AcrB, and the
introduction of the P223G mutation had no effect on the
formation of the bond, indicating that the P223G mutation did
not affect the conformation of the loop. In addition, the
formation of disulfide bond between C216–C234, which greatly
restricted the flexibility of the loop, had no effect on the drug
efflux activity when introduced into the fully functional Cys-less
AcrB background (Table 1). Assuming disulfide bond forms when
the subunit acquires its tertiary structure, prior to trimerization,
these results would suggest that the flexibility of the loop structure
is not critical for trimerization. This assumption is reasonable, as
studies have shown that intra-molecular disulfide bond in proteins
formed on the time scale of sec to min, comparable to the time it
takes to translate a polypeptide chain with the size of AcrB (1049
amino acid, assuming a translation rate of 10–15 amino acids per
second) [39,40]. In many cases the formation of disulfide bond is
actually coupled with protein folding [41]. These results
suggested that the loop remained rigid during trimerization.
Another line of evidence that support the ‘‘loop-first’’ mechanism
is the observation that the activity of AcrBP223Y is comparable or
slightly higher than that of AcrBP223G. If the tunnel forms first, a
loop with such a large side chain at the tip would have trouble
penetrating through the tunnel. If the loop remains rigid during
the trimerization process, then the introduction of a Pro to Gly
mutation may have caused the loop to become more flexible,
which would result in an increased entropy penalty when the loop
adopts a specific structure upon trimerization. However, entropy
penalty itself cannot completely account for the significant loss of
function in AcrBP223G, since the P224G mutation had no obvious
effect on protein function. P223 could be serving as a wedge at
the tip of the loop, which prevented the loop from slipping out of
the tunnel once the trimer formed.
A random mutagenesis study on a close homologue of AcrB,
MexB in Pseudomonas aeruginosa, has lead to the identification of a
functionally defective mutant with a point mutation in the loop,
G220S [42]. G220 is another conserved residue in the loop
(Figure 1D and 2). The authors found that the mutant expressed at
a level similar to that of WT MexB, and speculated that the G220S
mutation may have hindered the insertion of the loop into the
tunnel and thus decreased efficiency of MexB trimer formation
through changing the secondary structure of the loop and causing
steric problems. The position of the corresponding G220 in AcrB
structure locates right at the kink in the loop (Figure 1D), which
further confirmed the importance of the kink in stabilizing the
trimer structure. The loop locates right in between the TolC-
docking domain and pore-forming domain of AcrB. There is also a
possibility that in P223G mutation, transport-dependent confor-
mational change could have been affected, which may further
contribute to the observed drastic decrease of activity.
From an evolutionary perspective, protein oligomerization
offers clear functional advantages including enhanced structural
scaffolding to support and regulate function, increased sensitivity
to evolutionary pressure, and improved stability [43–45]. Howev-
er, the exact mechanisms by which proteins assemble into
oligomers remain poorly understood. Here we used a homo-
trimeric membrane protein, AcrB, as a model system and
investigated the connection between the oligomer stability and
protein activity. We found the mutation of a residue critical to
inter-subunit interaction ‘‘loosened’’ the AcrB trimer and thus
drastically decreased the transport activity of the efflux pump.
When tightened using an inter-subunit disulfide bond, the activity
of the mutant improved dramatically. In addition, our result
showed that during the trimerization of AcrB, the long protruding
loop remained rigid, which suggested that its binding partners in
the neighboring subunit underwent conformational adjustment to
form a tunnel to accommodate the loop.
Materials and Methods
Materials
Protein molecular weight markers for SDS-PAGE and BN-
PAGE were from Fermentas (Glen Burnie, MD) and Invitrogen
(Carlsbad, CA), respectively. The custom polyclonal rabbit anti-
AcrB was ordered from GenScript (Piscataway, NJ), produced
following a protocol as described [18]. All enzymes were from
New England Biolabs (Ipswich, MA). The parent WT (BW35113)
and acrB knockout strain (BW35113DacrB) strains were obtained
from the Yale E. coli genetic stock center. AG100A is a kind gift
from Dr. Hiroshi Nikaido.
Site-Directed Mutagenesis, Expression and Purification of
AcrB and its Mutants
Mutations were introduced into the acrB gene in plasmid
pQE70-AcrB using the QuikChange method (Agilent Technolo-
gies). Protein expression and purification was conducted as
described [32].
Drug Susceptibility Assays
Drug susceptibility was determined by two methods. The MICs
of erythromycin, novobiocin, rhodamine 6G, tetraphenylpho-
sphonium, and tetracycline as shown in Table 1 were determined
on agar plate without induction by the two-fold agar dilution
method [46]. Cells harboring pQE70-AcrB derived plasmids were
incubated on the plate at 37uC for 20 h and growth was evaluated.
To detect the effect of DTT, the drug susceptibilities experiments
were conducted in liquid cultures as described [18]. Briefly, the
exponential-phase cultures started from a single colony of freshly
transformed cells was diluted to a final OD600 of 0.1 unit with LB
broth. 10 ml of this dilute culture was used to inoculate each well of
a sterile 24-well culture plate containing 1 ml fresh LB medium.
The plate was incubated at 37uC with shaking at 200 rpm for
8 hours before the OD600 was measured. Each assay was repeated
at least three times.
Expression Level Analysis Using Western Blot
BW25113DacrB cells transformed with plasmids encoding AcrB
or its mutants were cultured at 37uC overnight. The cells were
AcrB Trimer Stability and Efflux Activity
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buffer, and lysed using a French press. Cell debris was removed
through a low-speed centrifugation and membrane vesicles were
collected by ultracentrifugation at 150,000 g for 1 h at 4uC.
Membrane vesicles were solubilized in sodium phosphate buffer
(pH 7.4) containing 2% (wt/vol) SDS at room temperature and
separated on a 8% SDS-PAGE gel. The proteins were transferred
to a nitrocellulose membrane (Millipore, Bedford, MA) and
detected as described [20].
CD Spectroscopy, Disulfide Trapping, and Blue Native
(BN)-PAGE Analysis
CD spectra and temperature denaturation scans were collected
on a JASCO J-810 spectrometer as described [20]. Disulfide
trapping was performed as described [32]. BN-PAGE was
performed as described [20].
Limited Trypsin Digestion
Trypsin was mixed with WT AcrB or AcrBP223G at the mass
ratio of 1:200 in buffer (10 mM sodium-phosphate, 50 mM NaCl,
10% glycerol, 0.05% n-Dodecyl b-D-maltoside (DDM), pH 7.5) at
room temperature. At indicated time, aliquots of sample were
withdrawn, quenched through the adding of SDS loading buffer
and phenylmethylsulfonyl fluoride (PMSF), and put on ice. The
samples were resolved on SDS-PAGE.
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